| Name | mesoderm development LRP chaperone |
| Description | Predicted to enable low-density lipoprotein particle receptor binding activity. Involved in ossification and protein folding. Located in endoplasmic reticulum. Implicated in osteogenesis imperfecta type 20. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMESD is fundamentally a specialized endoplasmic reticulum chaperone that orchestrates the proper folding and intracellular trafficking of multiligand receptors in the low‐density lipoprotein (LRP) family, most notably the Wnt co-receptors LRP5 and LRP6. Through its dual-domain structure—with a chaperone domain that stabilizes the immature β-propeller regions and an escort domain that safeguards the receptors during transit from the ER to the Golgi—MESD ensures that these complex proteins achieve conformations that allow them to reach the cell surface and engage in canonical Wnt signaling. Disruption of MESD function, as seen in cases where truncation or frameshift mutations cause its mislocalization (and in genetic rearrangements that prevent proper ER targeting), results in hypomorphic alleles that compromise receptor maturation, leading to severe developmental defects including defects in skeletal and dental formation, and even early embryonic lethality in animal models."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its intracellular role, MESD exhibits important extracellular functions. The recombinant MESD protein—and particularly peptides derived from its C-terminal region—can bind mature LRP5 and LRP6 receptors on the cell surface, antagonizing Wnt/β-catenin signaling by interfering with the binding of various Wnt ligands and modulators. This inhibitory capability has been demonstrated across different cell contexts, including prostate and breast cancer models, where it not only suppresses aberrant Wnt signaling but also enhances the cytotoxic effects of chemotherapeutic agents. Moreover, co-expression of MESD has been shown to markedly enhance the functional display of LRP5/6, thereby affecting the binding of secreted antagonists such as Dkk1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these findings underscore the dual functional roles of MESD both as an essential intracellular chaperone facilitating the maturation and safe trafficking of LRP receptors and as an extracellular modulator that can dampen Wnt signaling. The critical nature of MESD’s activity is highlighted by its association with developmental disorders such as osteogenesis imperfecta and its emerging potential as a therapeutic target in oncology, where modulating Wnt pathway dynamics could offer significant clinical benefits.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Imke M Veltman, Lilian A Vreede, Jinke Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddi200"}], "href": "https://doi.org/10.1093/hmg/ddi200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15917269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15917269"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yonghe Li, Wenyan Lu, Xi He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of LRP6-mediated Wnt signaling by molecular chaperone Mesd."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2006.09.011"}], "href": "https://doi.org/10.1016/j.febslet.2006.09.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16989816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16989816"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Janet K Lighthouse, Liqun Zhang, Jen-Chih Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Dyn (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvdy.22477"}], "href": "https://doi.org/10.1002/dvdy.22477"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21337463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21337463"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jianglei Chen, Chia-Chen Liu, Qianqian Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Two structural and functional domains of MESD required for proper folding and trafficking of LRP5/6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2011.01.010"}], "href": "https://doi.org/10.1016/j.str.2011.01.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21397183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21397183"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shahida Moosa, Guilherme L Yamamoto, Lutz Garbes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2019.08.008"}], "href": "https://doi.org/10.1016/j.ajhg.2019.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31564437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31564437"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Julian Stürznickel, Katharina Jähn-Rickert, Jozef Zustin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Compound Heterozygous Frameshift Mutations in MESD Cause a Lethal Syndrome Suggestive of Osteogenesis Imperfecta Type XX."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bone Miner Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbmr.4277"}], "href": "https://doi.org/10.1002/jbmr.4277"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33596325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33596325"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Richard J Murrills, Jeanne J Matteo, Bheem M Bhat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.22335"}], "href": "https://doi.org/10.1002/jcb.22335"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19746449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19746449"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Cuihong Lin, Wenyan Lu, Ling Zhai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.08.046"}], "href": "https://doi.org/10.1016/j.febslet.2011.08.046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21907199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21907199"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Cuihong Lin, Wenyan Lu, Wei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0058102"}], "href": "https://doi.org/10.1371/journal.pone.0058102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23469146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23469146"}]}]}]}
|
| NCBI Gene ID | 23184 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MESD has 1,634 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 38 datasets.
Click the + buttons to view associations for MESD from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MESD gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MESD protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MESD gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MESD gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing MESD protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MESD protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MESD protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MESD gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving MESD gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MESD gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MESD gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MESD gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MESD gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding MESD protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MESD gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MESD gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MESD gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MESD gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MESD gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MESD gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MESD gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MESD gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MESD gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MESD gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MESD gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MESD gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MESD protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MESD protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MESD gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MESD gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MESD gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MESD gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MESD gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MESD gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MESD gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MESD protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MESD protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MESD protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |